Bavarian secures massive loan from EIB
Denmark’s Bavarian Nordic has secured access to a loan of EUR 50 million from the European Investment Bank – money that will be used on the development of one of its vaccines.
BY STEFAN SINGH KAILAY
The European Investment Bank (EIB) has granted a loan facility of EUR 50 million to Bavarian Nordic, the Danish-based biotech company says in a press release.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
“We can only strike one partnership deal”
For abonnenter
”It’s a top five deal”
For abonnenter
Bavarian strikes historic Prostvac deal
For abonnenter
